NCT00026728View on ClinicalTrials.gov

Seroprevalence of Kaposi's Sarcoma Herpes Virus in the United States

CompletedOBSERVATIONAL
Enrollment

20,169

Participants

Timeline

Start Date

February 28, 2001

Study Completion Date

December 31, 2005

Conditions
Kaposi's SarcomaHerpesviridae Infection
Trial Locations (1)

20892

National Cancer Institute (NCI), Bethesda

All Listed Sponsors
lead

National Cancer Institute (NCI)

NIH

NCT00026728 - Seroprevalence of Kaposi's Sarcoma Herpes Virus in the United States | Biotech Hunter | Biotech Hunter